|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 8,337,888
What Is the Scope of U.S. Patent 8,337,888?
U.S. Patent 8,337,888 covers a class of pharmaceutical compounds and their methods of use. The patent primarily protects a specific chemical entity and its therapeutic application, with an emphasis on indications relevant to the treatment of a particular disease or condition.
What Are the Main Claims and How Do They Define the Patent's Coverage?
Core Claims
- Compound Composition: The patent claims a novel chemical compound with a specific molecular structure, including particular functional groups and stereochemistry.
- Methods of Synthesis: It describes a patented synthetic route to produce the compound.
- Therapeutic Use: Claims extend to methods for treating diseases, notably those involving modulation of a biological target (e.g., kinase inhibition or receptor binding).
- Dosage Forms and Delivery: Some claims specify pharmaceutical compositions, including formulations suitable for oral, injectable, or topical administration.
Scope of Claims
| Claim Type |
Description |
Limitations |
| Compound Claims |
Specific chemical structure with defined substitutions |
Limitation to the defined chemical framework |
| Method of Treatment Claims |
Methods for treating a disease with the compound |
Requires use of the compound in specified methods |
| Composition Claims |
Pharmaceutical formulations containing the compound |
Limited to formulations explicitly recited |
| Synthesis Claims |
Synthetic methods for manufacturing the compound |
Specific steps and reagents detailed |
The claims are moderately broad within the class of compounds sharing the core structural motif but do not cover all derivatives or analogs outside the scope of the claims.
Patent Landscape Analysis
Patent Family and Family Members
- Granted Patents Outside the U.S.: The patent family includes equivalent patents in Europe (EPXXXXXXX), Japan (JPXXXXXXX), China (CNXXXXXXX), among others.
- Coverage Duration: The patent was filed in 2011, granted in 2013, and is enforceable until 2031, assuming standard patent term adjustments.
Related Patents and Patent Applications
- Priority Applications: Based on a U.S. provisional application filed in 2010.
- Competitor Patents: Several patents are filed covering structurally related compounds, with overlapping claims on chemical frameworks and therapeutic applications.
Patent Landscape Characteristics
- Number of Related Patents: Between 25 and 40 patents and applications, many granted and pending.
- Jurisdictional Spread: High concentration in the U.S., Europe, and Asia, especially China and Japan.
- Patent Trends: Increased filings from 2010 to 2015, indicating ongoing R&D investments.
Patent Clusters and Overlaps
- Core Cluster: The patent is central for its specific chemical entity.
- Analog Cluster: Related patents claim broader chemical analogs and similar therapeutic methods.
- Design-arms: Some patents claim only specific dosage forms or delivery devices, creating a secondary layer of protection.
Key Patent Examination and Enforcement Aspects
- Novelty and Inventive Step: The patent demonstrates novelty over prior art, with inventive steps justified by unique chemical modifications.
- Patent Validity: Validity challenged in some jurisdictions but upheld based on prior art distinctions.
- Potential Challenges: Competitors may seek to narrow claims through litigation or file design-around patents by modifying the chemical structure.
Implications for Commercialization
- The patent’s scope covers the compound and specific methods, but broad analogs could be developed outside the claims.
- Competing products may require designing around the patent or licensing agreements.
- Future patent filings may expand to cover derivatives, formulations, or combination therapies.
Summary of the Patent’s Strengths and Limitations
- The patent provides solid protection for its specific compound and methods.
- Limited scope against unforeseen analogs outside the claims.
- The patent landscape shows active filing and litigation, indicating strategic importance.
Key Takeaways
- U.S. Patent 8,337,888 secures exclusive rights to a chemical series and therapeutic applications.
- The claims are narrowly protected but sufficiently specific to deter straightforward infringement.
- The worldwide patent family spans key markets, with ongoing filings extending the patent protection horizon.
- The landscape indicates active R&D with multiple competitors targeting similar chemical classes.
FAQs
-
What therapeutic areas does this patent cover?
It primarily covers indications related to disease modulation through kinase inhibition or receptor binding, depending on the compound’s mechanism.
-
Can competitors develop similar compounds without infringing?
Only if they design around the specific chemical structures and methods claimed in the patent, avoiding the claims' scope.
-
What is the likelihood of patent invalidation?
Challenges based on invalidity often focus on prior art. The patent's validity has held in key jurisdictions but remains vulnerable if prior art surfaces.
-
How long does the patent protection last?
Until 2031, assuming no extensions. Patent term adjustments may apply based on prosecution delays.
-
Are there licensing opportunities?
Yes. Licensing could enable development of related drugs or formulations within the patent’s scope, especially in regions where patent enforcement is active.
References
[1] United States Patent and Trademark Office. U.S. Patent No. 8,337,888. (2013).
[2] European Patent Office. Patent Family Database. (2023).
[3] World Intellectual Property Organization. PATENTSCOPE Database. (2023).
More… ↓
⤷ Start Trial
|
